Mostrar el registro sencillo del ítem

dc.rights.licenseopenen_US
hal.structure.identifierUniversidad de Antioquia = University of Antioquia [Medellín, Colombia]
dc.contributor.authorCASTRO-ALVAREZ, John Fredy
hal.structure.identifierUniversidad de Antioquia = University of Antioquia [Medellín, Colombia]
dc.contributor.authorGUTIERREZ-VARGAS, Johanna
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorDARNAUDERY, Muriel
IDREF: 124892264
hal.structure.identifierUniversidad de Antioquia = University of Antioquia [Medellín, Colombia]
dc.contributor.authorCARDONA-GOMEZ, Gloria Patricia
dc.date.accessioned2022-03-02T14:28:15Z
dc.date.available2022-03-02T14:28:15Z
dc.date.issued2011-06-01
dc.identifier.issn1939-0084en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/128796
dc.description.abstractEnRho-kinase (ROCK) is a downstream effector of RhoA, which has been associated with growth cone collapse and retraction in neurons. ROCK inhibition has been shown to protect against ischemic damage, thereby improving short-term collateral flow, inhibiting platelet aggregation, leukocyte adhesion, and preventing neuronal death. However, little is known about the long-term effects of ROCK inhibition on behavior and neuroprotection. The consequence of ROCK inhibition on ischemic rats' learning and spatial memory after 30 days of intracerebroventricular treatment was evaluated. It was found that Y27632 (ROCK inhibitor) reduced neurodegenerative markers, such as Fluoro-Jade, PHF (paired helicoidal filaments) immunoreactivity, and p25 protein levels, in the hippocampus of ischemic animals and improved learning and spatial memory tasks. However, Y27632 alone impaired sham animals' long-term memory. These findings demonstrated the beneficial impact of ROCK inhibition on tauopathy and altered p25 protein levels following global cerebral ischemia.
dc.language.isoENen_US
dc.subject.enAmides
dc.subject.enAnimals
dc.subject.enBrain Ischemia
dc.subject.enCyclin-Dependent Kinase 5
dc.subject.enDNA-Binding Proteins
dc.subject.enDisease Models
dc.subject.enAnimal
dc.subject.enEnzyme Inhibitors
dc.subject.enHippocampus
dc.subject.enInjections
dc.subject.enIntraventricular
dc.subject.enMale
dc.subject.enMaze Learning
dc.subject.enMemory Disorders
dc.subject.enNerve Degeneration
dc.subject.enNeuroprotective Agents
dc.subject.enPhosphorylation
dc.subject.enPyridines
dc.subject.enRats
dc.subject.enRats
dc.subject.enWistar
dc.subject.enSpatial Behavior
dc.subject.enrho-Associated Kinases
dc.subject.entau Proteins
dc.title.enROCK inhibition prevents tau hyperphosphorylation and p25/CDK5 increase after global cerebral ischemia.
dc.title.alternativeBehav Neuroscien_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1037/a0023167en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed21517148en_US
bordeaux.journalBehavioral Neuroscienceen_US
bordeaux.page465-72en_US
bordeaux.volume125en_US
bordeaux.hal.laboratoriesNutriNeurO (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINRAEen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.exportfalse
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Behavioral%20Neuroscience&rft.date=2011-06-01&rft.volume=125&rft.issue=3&rft.spage=465-72&rft.epage=465-72&rft.eissn=1939-0084&rft.issn=1939-0084&rft.au=CASTRO-ALVAREZ,%20John%20Fredy&GUTIERREZ-VARGAS,%20Johanna&DARNAUDERY,%20Muriel&CARDONA-GOMEZ,%20Gloria%20Patricia&rft.genre=article


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem